HK1155733A1 - 用於製備 -氧代-八氫-吲哚- -羧酸甲基酯及其衍生物的方法 - Google Patents

用於製備 -氧代-八氫-吲哚- -羧酸甲基酯及其衍生物的方法

Info

Publication number
HK1155733A1
HK1155733A1 HK11109931.0A HK11109931A HK1155733A1 HK 1155733 A1 HK1155733 A1 HK 1155733A1 HK 11109931 A HK11109931 A HK 11109931A HK 1155733 A1 HK1155733 A1 HK 1155733A1
Authority
HK
Hong Kong
Prior art keywords
octahydro
indole
oxo
derivatives
processes
Prior art date
Application number
HK11109931.0A
Other languages
English (en)
Inventor
Ernst Kuesters
Murat Acemoglu
Philipp Lustenberger
Gottfried Sedelmeier
Beat Schmidt
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41278189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1155733(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1155733A1 publication Critical patent/HK1155733A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK11109931.0A 2008-08-12 2011-09-21 用於製備 -氧代-八氫-吲哚- -羧酸甲基酯及其衍生物的方法 HK1155733A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8815608P 2008-08-12 2008-08-12
PCT/EP2009/060351 WO2010018154A1 (en) 2008-08-12 2009-08-10 Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof

Publications (1)

Publication Number Publication Date
HK1155733A1 true HK1155733A1 (zh) 2012-05-25

Family

ID=41278189

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11109931.0A HK1155733A1 (zh) 2008-08-12 2011-09-21 用於製備 -氧代-八氫-吲哚- -羧酸甲基酯及其衍生物的方法

Country Status (22)

Country Link
US (1) US8084487B2 (zh)
EP (1) EP2315748B1 (zh)
JP (1) JP5468608B2 (zh)
KR (1) KR101673634B1 (zh)
CN (1) CN102119151A (zh)
AU (1) AU2009281218B2 (zh)
BR (1) BRPI0917492A8 (zh)
CA (1) CA2732095C (zh)
CL (1) CL2011000296A1 (zh)
CO (1) CO6341608A2 (zh)
EC (1) ECSP11010883A (zh)
ES (1) ES2547269T3 (zh)
HK (1) HK1155733A1 (zh)
IL (1) IL210835A (zh)
MA (1) MA32618B1 (zh)
MX (1) MX2011001664A (zh)
MY (1) MY151183A (zh)
NZ (1) NZ590753A (zh)
PE (1) PE20110415A1 (zh)
RU (1) RU2513856C2 (zh)
WO (1) WO2010018154A1 (zh)
ZA (1) ZA201100558B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012084873A1 (en) 2010-12-20 2012-06-28 Novartis Ag 4- (hetero) aryl - ethynyl - octahydro - indole - 1 - carboxylic acid esters
US9067881B2 (en) 2011-01-24 2015-06-30 Novartis Ag 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives
EP2650284A1 (en) 2012-04-10 2013-10-16 Merz Pharma GmbH & Co. KGaA Heterocyclic derivatives as metabotropic glutamate receptor modulators
JP2020529975A (ja) 2017-07-31 2020-10-15 ノバルティス アーゲー コカイン使用の低減又はコカイン使用再燃の予防におけるマボグルラントの使用
CA3067688A1 (en) 2017-07-31 2019-02-07 Novartis Ag Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
US20220175793A1 (en) * 2019-01-29 2022-06-09 Novartis Ag The use of an mglur5 antagonist for treating opioid analgesic tolerance
CA3181961A1 (en) 2020-07-17 2022-01-20 Novartis Ag Use of mglur5 antagonists
US20240050408A1 (en) 2020-12-11 2024-02-15 Novartis Ag Use of mglur5 antagonists for treating amphetamine addiction
US20240082215A1 (en) 2020-12-14 2024-03-14 Novartis Ag Use of mglur5 antagonists for treating gambling disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) 2001-12-04 2002-01-23 Novartis Ag Organic compounds
GB0514296D0 (en) * 2005-07-12 2005-08-17 Novartis Ag Organic compounds
WO2008031550A2 (en) * 2006-09-11 2008-03-20 Novartis Ag Nicotinic acid derivatives as modulators of metabotropic glutanate receptors
SG185293A1 (en) * 2007-10-12 2012-11-29 Novartis Ag Organic compounds
AU2009265760B2 (en) * 2008-06-30 2013-07-18 Novartis Ag Combinations comprising mGluR modulators for the treatment of parkinson's disease

Also Published As

Publication number Publication date
MA32618B1 (fr) 2011-09-01
CN102119151A (zh) 2011-07-06
ES2547269T3 (es) 2015-10-05
NZ590753A (en) 2012-06-29
MY151183A (en) 2014-04-30
IL210835A (en) 2016-05-31
EP2315748B1 (en) 2015-06-24
AU2009281218B2 (en) 2013-05-16
IL210835A0 (en) 2011-04-28
EP2315748A1 (en) 2011-05-04
AU2009281218A1 (en) 2010-02-18
JP2011530566A (ja) 2011-12-22
KR20110042222A (ko) 2011-04-25
CO6341608A2 (es) 2011-11-21
WO2010018154A1 (en) 2010-02-18
US8084487B2 (en) 2011-12-27
JP5468608B2 (ja) 2014-04-09
ZA201100558B (en) 2011-10-26
CA2732095C (en) 2017-04-25
US20110144352A1 (en) 2011-06-16
PE20110415A1 (es) 2011-07-04
CA2732095A1 (en) 2010-02-18
RU2011108663A (ru) 2012-09-20
BRPI0917492A8 (pt) 2016-07-05
RU2513856C2 (ru) 2014-04-20
BRPI0917492A2 (pt) 2015-08-04
KR101673634B1 (ko) 2016-11-07
MX2011001664A (es) 2011-03-25
CL2011000296A1 (es) 2011-11-04
ECSP11010883A (es) 2011-04-29

Similar Documents

Publication Publication Date Title
IL206664A0 (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
HK1155733A1 (zh) 用於製備 -氧代-八氫-吲哚- -羧酸甲基酯及其衍生物的方法
IL234285B (en) A process for the preparation of boronate ester compounds and their intermediates
ZA201203615B (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
ZA201201791B (en) Method for the preparation of 2,5-furandicarboxylic acid and esters thereof
PL2352497T3 (pl) Proces przygotowania estrów aminokwasowych delta-9-thc
EP2381772A4 (en) METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF N-ACYLATED-4-ARYL BETA-AMINO ACID DERIVATIVES
GB2452358B (en) Preparation of bile acids
IL220211A0 (en) Process for the preparation of 1-alkyl-/1-aryl-5-pyrazolecarboxylic acid derivatives
GB0624963D0 (en) Derivatives of 188-Glycyrrhetinic Acid
HK1166065A1 (zh) 用於製備丙酸衍生物的方法
IL213354A (en) Alpha-monoclonal fatty acid alpha history for use as a drug
EG25838A (en) Process for the preparation of amino acid methyl esters
IL207557A0 (en) Process for the preparation of pregnane derivatives
PL2285780T3 (pl) Sposoby i związki do wytwarzania normorfinanów
ZA201205062B (en) Process for the preparation of propionic acid derivatives
IL192554A0 (en) Controlled release formulation of divalproic acid and its derivatives
HK1129687A1 (en) A process for the preparation of poly-alfa-glutamic acid and derivatives thereof
GB2460350B (en) Intermediates for the preparation of bile acids
GB0801878D0 (en) Process for the conversion of fatty acids and derivatives thereof
GB0810779D0 (en) Process for the conversion of fatty acids and derivatives thereof
ZA200605368B (en) Gallic acid derivative and process of preparing the same
PL388932A1 (pl) Sposób otrzymywania fluorosilikonów i ich pochodnych
EP2311841A4 (en) PROCESS FOR THE PRODUCTION OF SARAGOSSAIC ACIDS AND DERIVATIVES THEREOF
PL393253A1 (pl) Nowe pochodne kwasu betulinowego i sposób ich otrzymywania

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190813